{
    "clinical_study": {
        "@rank": "105885", 
        "acronym": "LIFEMARKER", 
        "biospec_descr": {
            "textblock": "Blood samples will be stored frozen for future analysis."
        }, 
        "biospec_retention": "Samples With DNA", 
        "brief_summary": {
            "textblock": "The purpose of this study is to determine whether levels of inflammatory markers in\n      circulating blood can correlate with risk for dangerous heart rhythms.  Patients with\n      systolic heart failure, which has been shown to increase risk for dangerous heart rhythms,\n      will be enrolled.  All subjects will have an implantable cardioverter-defibrillator (ICD) in\n      place, which allows regular evaluation of heart rhythm."
        }, 
        "brief_title": "Circulating Biomarkers and Ventricular Tachyarrhythmia", 
        "completion_date": {
            "#text": "May 2015", 
            "@type": "Anticipated"
        }, 
        "condition": [
            "Cardiomyopathy", 
            "Ventricular Tachycardia", 
            "Ventricular Fibrillation"
        ], 
        "condition_browse": {
            "mesh_term": [
                "Tachycardia", 
                "Ventricular Fibrillation", 
                "Tachycardia, Ventricular", 
                "Cardiomyopathies"
            ]
        }, 
        "eligibility": {
            "criteria": {
                "textblock": "Inclusion Criteria:\n\n          -  left ventricular ejection fraction [LVEF] <=35%\n\n          -  ICD implant\n\n        Exclusion Criteria:\n\n          -  Recent myocardial infarction (12 weeks)\n\n          -  Recent revascularization (12 weeks)\n\n          -  Recent hospitalization for any cause (6 weeks)\n\n          -  History of rheumatologic disease"
            }, 
            "gender": "Both", 
            "healthy_volunteers": "No", 
            "maximum_age": "N/A", 
            "minimum_age": "18 Years", 
            "sampling_method": "Non-Probability Sample", 
            "study_pop": {
                "textblock": "Patients with cardiomyopathy (left ventricular ejection fraction [LVEF] <=35%) who are\n        followed at our institution's ICD device clinic will have levels of circulating biomarkers\n        (hs-CRP, IL-6, TNF-alpha, IL-1, sST2, MMP-1, CICP, CITP) and BNP assessed at three-month\n        intervals for at least one year. Patients will be excluded from the study if they have had\n        a recent myocardial infarction or PCI (within three months), or recent hospitalization.\n\n        Patients with obvious primary inflammatory conditions (such as lupus and rheumatoid\n        arthritis) will be excluded. Additionally, significant events (e.g., HF hospitalizations,\n        revascularization, medication changes, and death) will be tracked at each follow up visit\n        for further statistical analysis."
            }
        }, 
        "enrollment": {
            "#text": "200", 
            "@type": "Anticipated"
        }, 
        "firstreceived_date": "July 1, 2013", 
        "has_expanded_access": "No", 
        "id_info": {
            "nct_id": "NCT01892462", 
            "org_study_id": "ISRCRM400003"
        }, 
        "is_fda_regulated": "No", 
        "lastchanged_date": "July 3, 2013", 
        "location": {
            "contact": {
                "email": "dmorin@ochsner.org", 
                "last_name": "Daniel P Morin, MD, MPH, FHRS", 
                "phone": "5048425059"
            }, 
            "facility": {
                "address": {
                    "city": "New Orleans", 
                    "country": "United States", 
                    "state": "Louisiana", 
                    "zip": "70121"
                }, 
                "name": "Ochsner Health System"
            }, 
            "investigator": {
                "last_name": "Daniel P Morin, MD MPH", 
                "role": "Principal Investigator"
            }, 
            "status": "Recruiting"
        }, 
        "location_countries": {
            "country": "United States"
        }, 
        "number_of_groups": "1", 
        "official_title": "Circulating Biomarkers and Ventricular Tachyarrhythmia", 
        "overall_official": {
            "affiliation": "Ochsner Medical Foundation", 
            "last_name": "Daniel P Morin, MD MPH", 
            "role": "Principal Investigator"
        }, 
        "overall_status": "Recruiting", 
        "oversight_info": {
            "authority": "United States: Food and Drug Administration", 
            "has_dmc": "Yes"
        }, 
        "phase": "N/A", 
        "primary_completion_date": {
            "#text": "May 2015", 
            "@type": "Anticipated"
        }, 
        "primary_outcome": {
            "measure": "to evaluate a large population of heart failure patients with regard to circulating biomarkers and rates of subsequent ventricular arrhythmias.", 
            "safety_issue": "No", 
            "time_frame": "1 year"
        }, 
        "required_header": {
            "download_date": "ClinicalTrials.gov processed this data on June 04, 2014", 
            "link_text": "Link to the current ClinicalTrials.gov record.", 
            "url": "http://clinicaltrials.gov/show/NCT01892462"
        }, 
        "responsible_party": {
            "investigator_affiliation": "Ochsner Health System", 
            "investigator_full_name": "Dr. Daniel P Morin, MD MPH FHRS", 
            "investigator_title": "Cardiac Electrophysiologist, Director of Cardiovascular Research", 
            "responsible_party_type": "Principal Investigator"
        }, 
        "source": "Ochsner Health System", 
        "sponsors": {
            "collaborator": {
                "agency": "Boston Scientific Corporation", 
                "agency_class": "Industry"
            }, 
            "lead_sponsor": {
                "agency": "Ochsner Health System", 
                "agency_class": "Other"
            }
        }, 
        "start_date": "June 2012", 
        "study_design": "Observational Model: Cohort, Time Perspective: Prospective", 
        "study_type": "Observational", 
        "verification_date": "July 2013"
    }
}